Status:
UNKNOWN
Impact of OAB Symptoms on Quality of Life in Croatia
Lead Sponsor:
University of Zagreb
Conditions:
Overactive Bladder
Eligibility:
FEMALE
18-65 years
Brief Summary
Overactive bladder (OAB) has a negative impact on the daily activities of affected individuals. OAB affects an estimated 12-17% of adults and has a similar reported prevalence in men and women. It has...
Eligibility Criteria
Inclusion
- consenting adult patients who had an OAB diagnosis by their healthcare practitioner and were about to start mirabegron treatment as part of routine clinical practice were eligible for enrollment.
Exclusion
- mixed incontinence where stress incontinence was the predominant symptom (as determined by the investigator)
- severe uncontrolled hypertension (i.e. systolic blood pressure ≥180 mm Hg and/or diastolic blood pressure ≥110 mm Hg)
- anxiety and/or depression
- pregnancy
- women who reported having either a current or previous (within one month) urinary tract infection
Key Trial Info
Start Date :
May 10 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2022
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT04865328
Start Date
May 10 2021
End Date
May 1 2022
Last Update
April 29 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical Hospital Centre Zagreb, Croatia
Zagreb, Croatia, 10 000